This CTD dossier owner and manufacturer has been a leading force in the Middle East region for over a century, establishing a strong reputation for providing health solutions. They operate in both healthcare and agriculture, with a focus on the development, production, and marketing of prescription and over-the-counter medications, supplements, and medical devices. They have a strong track record of export activities, particularly in Asia, Africa, and Europe. Their production adheres to stringent international quality standards, including GMP certification. They engage in both in-licensing and out-licensing agreements to expand their product portfolio. Key therapy areas include oncology, cardiology, and rare diseases. Dosage forms include solids, liquids, and injectables.